Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'Ftc-Hiv'
Ftc-Hiv published presentations and documents on DocSlides.
DTG + TAF/FTC vs DTG + TDF/FTC vs EFV/TDF/FTC
by iris
ADVANCE. . Design. Primary endpoint. Proportion ...
Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV
by kylo
Andrew Hill, Francois Venter, Eric . Delaporte. , ...
Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV: ADVANCE and NAMSAL trials
by luanne-stotts
Progressive rises in weight and clinical obesity ...
TDF-FTC versus Placebo as HIV PrEP for Transgender Women
by shmuel184
iPrEx. Trial . Substudy. TDF-FTC versus Placebo a...
Elvitegravir-Cobicistat-TAF-FTC in Hepatitis B Coinfection
by melanie
Study 1249. Elvitegravir-Cobicistat-TAF-FTC in HIV...
Switching from TDF/FTC to TAF/
by fanny
FTC. Study 311-1089. Switching from TDF/FTC to TAF...
DTG + 3TC versus DTG + TDF-FTC as Initial ART
by della
GEMINI 1 and GEMINI 2: Week 48 Data. DTG + 3TC . v...
Switch to EVG/c/FTC/TDF
by liane-varnes
STRATEGY-PI . Study. STRATEGY-NNRTI . Study. Desi...
PrEP to Prevent HIV and
by kimberly
Promote Sexual Health. www.hivguidelines.org. MAY ...
HIV Update Ardis Moe, M.D.
by nonhurmer
amoe@mednet.ucla.edu. UCLA CARE clinic/NEVHC Van N...
HIV Medicine From Guidelines to Practice
by jubilantbikers
Kiat. . Ruxrungtham. Professor of Medicine, . Chu...
PrEP to Prevent HIV and Promote Sexual Health
by cheryl-pisano
PrEP to Prevent HIV and Promote Sexual Health www...
Treating and Preventing HIV in 2019: Interactive Cases From the Clinic(ians)
by alida-meadow
Treating and Preventing HIV in 2019: Interactive ...
Pre-Exposure Prophylaxis ( PrEP ) for HIV Infection Jeffrey D. Klausner, MD, MPH
by kittie-lecroy
Pre-Exposure Prophylaxis ( PrEP ) for HIV Infect...
Rajesh T. Gandhi, MD Director, HIV Clinical Services and Education
by calandra-battersby
Massachusetts General Hospital. Boston, Massachus...
HIV Medicine From Guidelines to Practice
by cheryl-pisano
Kiat. . Ruxrungtham. Professor of Medicine, . Ch...
Pre-exposure Prophylaxis for HIV Prevention
by pamella-moone
Efficacy and the importance of adherence. Joanne ...
HIV/AIDS HIV There are two types of HIV virus HIV 1 and HIV 2 ,most cases are caused by type 1 ,t
by phoebe
HIV1 and slower to progress to AIDS.. Most cases a...
Raltegravir + Darunavir/r versus TDF-FTC + Darunavir/r RADAR Trial
by keanu817
RADAR Trial. Raltegravir. + Darunavir/r versus TD...
Switch from Efavirenz + ZDV-3TC to Efavirenz + TDF-FTC
by ramon803
SWEET Trial . Switch to Efavirenz + TDF-FTC . SWEE...
Elvitegravir-Cobicistat-TAF-FTC in Renal Impairment
by carl
Study 112. Elvitegravir-Cobicistat-TAF-FTC in Rena...
Switching to TDF-FTC from ABC-3TC for Hyperlipidemia
by trinity
ROCKET II. Switching to TDF-FTC from ABC-3TC . for...
Comments of Prescription Access Litigation Project and Others on FTC P
by jainy
almost-inevitable patent infringement lawsuit from...
FTCA Coverage for Individuals at Free Clinics
by phoebe-click
Technical Assistance Call. PIN 2010-02. Departmen...
FTC Driver Station
by faustina-dinatale
Setup and Operatio. n. Mike Zook . 20-Sep-2016. H...
When and What To Start Melanie A. Thompson, MD
by paxton651
Thacker & Thompson, MD. Atlanta, Georgia. Fina...
Optimization of Antiretroviral Therapy
by belinda
With Emergence of Comorbidities. Roger J. . Bedimo...
Thinking of Now and Tomorrow: Emerging Treatment Paradigms
by deena
Pedro Cahn. Disclosures. Advisory. . boards. : Me...
Cabotegravir, Long-acting Injectable
by jacey
Last Updated: October 6, 2023. Prepared by:. David...
IAS – USA Fall New York Course: Case Discussion
by jalin
Luke . Jerram. Disclosures: Educational grant supp...
Eric S. Daar , MD Michael S.
by ButterflyHeart
Saag. , MD. Antiretroviral Therapy:. A Case-Based ...
Cases From the Clinic( ians
by ImNotABaby
):. Antiretroviral Therapy Cases . and . Panel Dis...
Interactive ART Cases From the Clinic: Is There One Right Answer?
by megan
Joseph J. Eron, Jr, MD. Professor of Medicine. Uni...
CROI Update: Best of Boston
by triclin
p. resented by. NCATEC. March . 18, . 2014. David ...
How to assess the efficacy of new strategies for the prevention of HIV – experience from the HVTN
by tawny-fly
Sinead Delany-Moretlwe. Wits RHI, University of t...
Eric S. Daar , MD Professor of Medicine
by faustina-dinatale
David Geffen School of Medicine. at University of...
What’s Next – and When:
by sherrill-nordquist
An Update on Injectable . P. revention. Alex R Ri...
Comprehensive Guideline Summary
by aaron
Guidelines for the Use of Antiretroviral Agents. ...
ART Initiation: PrEP and
by alida-meadow
Treatment-naïve Patients . Clinical Instructor, ...
Clinical Management Module
by stefany-barnette
4. . (b) . Risks and Side Effects. Overview. Res...
Load More...